GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 17 filers reported holding GALMED PHARMACEUTICALS LTD in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $109,000 | +0.9% | 12,000 | 0.0% | 0.02% | -4.8% |
| Q3 2017 | $108,000 | +45.9% | 12,000 | 0.0% | 0.02% | +40.0% |
| Q2 2017 | $74,000 | +27.6% | 12,000 | 0.0% | 0.02% | +25.0% |
| Q1 2017 | $58,000 | +38.1% | 12,000 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $42,000 | -20.8% | 12,000 | 0.0% | 0.01% | -30.8% |
| Q3 2016 | $53,000 | -1.9% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $54,000 | -8.5% | 12,000 | 0.0% | 0.01% | -13.3% |
| Q1 2016 | $59,000 | -35.2% | 12,000 | 0.0% | 0.02% | -31.8% |
| Q4 2015 | $91,000 | +2.2% | 12,000 | 0.0% | 0.02% | 0.0% |
| Q3 2015 | $89,000 | -26.4% | 12,000 | 0.0% | 0.02% | -24.1% |
| Q2 2015 | $121,000 | +7.1% | 12,000 | 0.0% | 0.03% | +7.4% |
| Q1 2015 | $113,000 | +94.8% | 12,000 | +20.0% | 0.03% | +92.9% |
| Q4 2014 | $58,000 | +241.2% | 10,000 | +400.0% | 0.01% | +250.0% |
| Q3 2014 | $17,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,799,694 | $1,224,000 | 0.06% |
| BRAVE ASSET MANAGEMENT INC | 11,470 | $8,000 | 0.00% |
| Western Wealth Management, LLC | 59,074 | $38,000 | 0.00% |
| PYA Waltman Capital, LLC | 1,000 | $1,000 | 0.00% |
| TSFG, LLC | 3,000 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 27,177 | $18,000 | 0.00% |
| Renaissance Technologies | 31,600 | $21,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 50,748 | $35,000 | 0.00% |
| CITIGROUP INC | 3,700 | $3,000 | 0.00% |
| UBS Group AG | 6,064 | $4,000 | 0.00% |